Endocytic Trafficking and Human Diseases

内吞贩运与人类疾病

基本信息

项目摘要

Mucolipidosis type IV (MLIV) is an autosomal recessive disorder characterized by acute psychomotor delays, achlorydria, and visual abnormalities including retinal degeneration, corneal clouding, optic atrophy, and strabismus. Lysosomal inclusions are found in most tissues in MLIV patients. The composition of the storage material is heterogeneous and includes lipids and mucopolysaccharides forming characteristic multiconcentric lamellae, as well as soluble, granulated proteins. MLIV is caused by mutations in mucolipin-1 (MCOLN1, also known as TRPML1), an endo-lysosomal cation channel belonging to the transient receptor potential (TRP) superfamily of ion channels. Whole cell patch clamp, as well as recording of native endolysosomal membranes, suggest that MCOLN1 functions as an inwardly (from lumen to cytoplasm) rectifying channel permeable to Ca2+, Na+, K+ and Fe2+/ Mn2+ whose activity is potentiated by low pH. To better understand the pathology of this disease, we aimed to generate a MLIV disease model in zebrafish. Two putative zebrafish MCOLN1 co-orthologs have been identified, mcoln1.1 and mcoln1.2. By using specific Zinc Finger Nucleases (ZFN), we successfully created two independent mcoln1.1 knockout lines. Initial characterization of mcoln1.1 homozygous null embryos revealed noticeable cell death in the eye. Cell death was confirmed as cell apoptosis by TUNEL staining in both mcoln1.1 knockout lines. When mcoln1.1-/- fish embryos were injected with mcoln1.2 morpholino, the observed phenotype become even more apparent and increased apotosis was detected in the whole body of the mcoln1 null embryos, thus suggesting some level of redundancy between mcoln1.1 and mcoln1.2. To further confirm these observations we have made use of the recently developed CRISPR/Cas9-mediated genome editing technology to generate mcoln1.2-KO and mcoln1.1/mcoln1.2 double KO lines. Initial characterization of these zebrafish lines indicates that the mcoln1.1/mcoln1.2 double KO animals reproduce many of the abnormalities observed in MLIV patients, including eye abnormalities and muscle defects. These results indicate that our zebrafish line constitutes a valuable model for the study of MLIV. Moreover, this animal model has the potential to facilitate large-scale drug screening as well as preclinical drug evaluation for the treatment of MLIV.
IV 型粘脂沉积症 (MLIV) 是一种常染色体隐性遗传疾病,其特征为急性精神运动迟缓、胃酸缺乏和视觉异常,包括视网膜变性、角膜混浊、视神经萎缩和斜视。 MLIV 患者的大多数组织中均发现溶酶体包涵体。储存材料的成分是异质的,包括形成特征性多同心片层的脂质和粘多糖,以及可溶性颗粒状蛋白质。 MLIV 是由 mucolipin-1(MCOLN1,也称为 TRPML1)突变引起的,粘蛋白-1 是一种内溶酶体阳离子通道,属于离子通道瞬时受体电位 (TRP) 超家族。全细胞膜片钳以及天然内溶酶体膜的记录表明,MCOLN1 充当可渗透 Ca2+、Na+、K+ 和 Fe2+/Mn2+ 的内部(从腔到细胞质)整流通道,其活性因低 pH 值而增强。 为了更好地了解这种疾病的病理学,我们的目标是在斑马鱼中建立 MLIV 疾病模型。已鉴定出两种假定的斑马鱼 MCOLN1 直系同源物:mcoln1.1 和 mcoln1.2。通过使用特定的锌指核酸酶 (ZFN),我们成功创建了两个独立的 mcoln1.1 敲除系。 mcoln1.1 纯合无效胚胎的初步表征显示眼睛中有明显的细胞死亡。在两个 mcoln1.1 敲除系中,通过 TUNEL 染色确认细胞死亡为细胞凋亡。当 mcoln1.1-/- 鱼胚胎注射 mcoln1.2 吗啉时,观察到的表型变得更加明显,并且在 mcoln1 无效胚胎的整个身体中检测到细胞凋亡增加,从而表明 mcoln1.1 和 mcoln1.2 之间存在一定程度的冗余。为了进一步证实这些观察结果,我们利用最近开发的 CRISPR/Cas9 介导的基因组编辑技术来生成 mcoln1.2-KO 和 mcoln1.1/mcoln1.2 双 KO 系。这些斑马鱼系的初步特征表明,mcoln1.1/mcoln1.2 双 KO 动物再现了 MLIV 患者中观察到的许多异常,包括眼睛异常和肌肉缺陷。这些结果表明我们的斑马鱼系构成了 MLIV 研究的有价值的模型。此外,该动物模型有可能促进大规模药物筛选以及治疗 MLIV 的临床前药物评价。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rosa Puertollano-Moro其他文献

Rosa Puertollano-Moro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rosa Puertollano-Moro', 18)}}的其他基金

Role of endolysosomal channels in calcium homeostasis and trafficking
内溶酶体通道在钙稳态和运输中的作用
  • 批准号:
    9572295
  • 财政年份:
  • 资助金额:
    $ 47.24万
  • 项目类别:
Regulation of the Endo/Lysosomal pathway
内切/溶酶体途径的调节
  • 批准号:
    10008790
  • 财政年份:
  • 资助金额:
    $ 47.24万
  • 项目类别:
Endocytic Trafficking and Human Diseases
内吞贩运与人类疾病
  • 批准号:
    8939746
  • 财政年份:
  • 资助金额:
    $ 47.24万
  • 项目类别:
Lysosome biogenesis and homeostasis
溶酶体生物发生和稳态
  • 批准号:
    10253872
  • 财政年份:
  • 资助金额:
    $ 47.24万
  • 项目类别:
Role of endolysosomal channels in calcium homeostasis and trafficking
内溶酶体通道在钙稳态和运输中的作用
  • 批准号:
    9157399
  • 财政年份:
  • 资助金额:
    $ 47.24万
  • 项目类别:
Role of endolysosomal channels in calcium homeostasis and trafficking
内溶酶体通道在钙稳态和运输中的作用
  • 批准号:
    8939851
  • 财政年份:
  • 资助金额:
    $ 47.24万
  • 项目类别:
Lysosome biogenesis and homeostasis
溶酶体生物发生和稳态
  • 批准号:
    8939900
  • 财政年份:
  • 资助金额:
    $ 47.24万
  • 项目类别:
Lysosome biogenesis and homeostasis
溶酶体生物发生和稳态
  • 批准号:
    9353144
  • 财政年份:
  • 资助金额:
    $ 47.24万
  • 项目类别:
Lysosomal Diseases
溶酶体疾病
  • 批准号:
    10253790
  • 财政年份:
  • 资助金额:
    $ 47.24万
  • 项目类别:
Lysosomal Diseases
溶酶体疾病
  • 批准号:
    10008747
  • 财政年份:
  • 资助金额:
    $ 47.24万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 47.24万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 47.24万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 47.24万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 47.24万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 47.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 47.24万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 47.24万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 47.24万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 47.24万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 47.24万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了